Fluorescence molecular painting of enveloped viruses

Molecular Biotechnology

Volumn 53, Issue 1, 2013, Pages 9-18

  Metzner, Christoph ^a   Kochan, Feliks ^a   Dangerfield, John A ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b Anovasia Pte Ltd   (Singapore)

Author keywords

Fluorescence labeling; Gene therapy; GPI anchored protein; Herpesvirus; HIV; Influenza; Lentivirus; Molecular painting; Surface modification; Viral attachment

Indexed keywords

FLUORESCENCE LABELING; GPI-ANCHORED PROTEIN; HERPESVIRUS; HIV; INFLUENZA; LENTIVIRUS; VIRAL ATTACHMENT;

DISEASES; FLOW CYTOMETRY; FLUORESCENCE; GENE THERAPY; GENE TRANSFER; PROTEINS; SURFACE TREATMENT;

VIRUSES;

DEXTRAN SULFATE; FLUORESCENT DYE; GLYCOSYLPHOSPHATIDYLINOSITOL; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENVELOPED VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE MOLECULAR PAINTING; IMMUNOBLOTTING; NONHUMAN; PROTEIN EXPRESSION; VIRUS; VIRUS ATTACHMENT; VIRUS ENVELOPE;

ANIMALS; DEXTRAN SULFATE; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; GLYCOSYLPHOSPHATIDYLINOSITOLS; GPI-LINKED PROTEINS; GREEN FLUORESCENT PROTEINS; HERPESVIRIDAE; IMMUNOBLOTTING; INFLUENZA A VIRUS; LENTIVIRUS; MADIN DARBY CANINE KIDNEY CELLS; PHYLOGENY; VIRION; VIRUS ATTACHMENT;

HERPESVIRIDAE; LENTIVIRUS;

EID: 84871649643     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-012-9616-6     Document Type: Article

References (30)

1. Yang, L., Bailey, L., Baltimore, D., & Wang, P. (2006). Targeting lentiviral vectors to specific cell types in vivo. Proceedings of National Academy of Sciences United States of America, 103, 11479-11484. (Pubitemid 44182477)
2. Waehler, R., Russell, S. J., & Curiel, D. T. (2007). Engineering targeted viral vectors for gene therapy. Nature Reviews Genetics, 8, 573-587. (Pubitemid 47077278)
3. Breun, S., Salmons, B., Gunzburg, W. H., & Baumann, J. G. (1999). Protection of MLV vector particles from human complement. Biochemical and Biophysical Research Communications, 264, 1-5. (Pubitemid 29500453)
4. Kaikkonen, M. U., Yla-Herttuala, S., & Airenne, K. J. (2011). How to avoid complement attack in baculovirus-mediated gene delivery. Journal of Invertebrate Pathology, 107(Suppl), S71-S79.
5. Skountzou, I., Quan, F. S., Gangadhara, S., Ye, L., Vzorov, A., Selvaraj, P., et al. (2007). Incorporation of glycosylphosphatidylinositol-anchored granulocyte-macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles. Journal of Virology, 81, 1083-1094. (Pubitemid 46167831)
6. Wong, S., & Kwon, Y. J. (2011). Synthetically functionalized retroviruses produced from the bioorthogonally engineered cell surface. Bioconjugate Chemistry, 22, 151-155.
7. Croyle, M. A., Callahan, S. M., Auricchio, A., Schumer, G., Linse, K. D., Wilson, J. M., et al. (2004). PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. Journal of Virology, 78, 912-921. (Pubitemid 38067612)
8. Schellingerhout, D., & Bogdanov, A. A., Jr. (2002). Viral imaging in gene therapy noninvasive demonstration of gene delivery and expression. Neuroimaging Clinics of North America, 12, 571-581. (Pubitemid 36015492)
9. Kaikkonen, M. U., Viholainen, J. I., Narvanen, A., Yla-Herttuala, S., & Airenne, K. J. (2008). Targeting and purification of metabolically biotinylated baculovirus. Human Gene Therapy, 19, 589-600. (Pubitemid 351913529)
10. Yang, G., Zhong, Q., Huang, W., Reiser, J., & Schwarzenberger, P. (2006). Retrovirus molecular conjugates: A versatile and efficient gene transfer vector system for primitive human hematopoietic progenitor cells. Cancer Gene Therapy, 13, 460-468.
11. Snitkovsky, S., & Young, J. A. (2002). Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology, 292, 150-155.
12. Metzner, C., Mostegl, M. M., Gunzburg, W. H., Salmons, B., & Dangerfield, J. A. (2008). Association of glycosylphosphatidylinositol-anchored protein with retroviral particles. FASEB Journal, 22, 2734-2739.
13. Metzner, C., Salmons, B., Gunzburg, W. H., & Dangerfield, J. A. (2008). Rafts, anchors and viruses - A role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors. Virology, 382, 125-131.
14. Blake, D. A., Bovin, N. V., Bess, D., & Henry, S. M. (2011). FSL constructs: A simple method for modifying cell/virion surfaces with a range of biological markers without affecting their viability. Journal of Visualized Experiments.
15. Mukherjee, N. G., Lyon, L. A., & Le Doux, J. M. (2009). Rapid modification of retroviruses using lipid conjugates. Nanotechnology, 20, 065103.
16. Dangerfield, J. A., Legler, D., & Metzner, C. (2009). Surface engineering of biomembranes with GPI-anchored proteins and its applications. In J. A. Dangerfield & C. Metzner (Eds.), GPI membrane anchors - The much needed link (pp. 116-137). Oak Park, IL: Bentham Science Publishers.
17. Eisenhaber, B., Bork, P., & Eisenhaber, F. (2001). Post-translational GPI lipid anchor modification of proteins in kingdoms of life: Analysis of protein sequence data from complete genomes. Protein Engineering, 14, 17-25. (Pubitemid 32318934)
18. Legler, D. F., Doucey, M. A., Schneider, P., Chapatte, L., Bender, F. C., & Bron, C. (2005). Differential insertion of GPI-anchored GFPs into lipid rafts of live cells. FASEB Journal, 19, 73-75. (Pubitemid 40069922)
19. Brodsky, R. A., Jane, S. M., Vanin, E. F., Mitsuya, H., Peters, T. R., Shimada, T., et al. (1994). Purified GPI-anchored CD4DAF as a receptor for HIV-mediated gene transfer. Human Gene Therapy, 5, 1231-1239.
20. Premkumar, D. R., Fukuoka, Y., Sevlever, D., Brunschwig, E., Rosenberry, T. L., Tykocinski, M. L., et al. (2001). Properties of exogenously added GPI-anchored proteins following their incorporation into cells. Journal of Cellular Biochemistry, 82, 234-245. (Pubitemid 32606287)
21. Tykocinski, M. L., Shu, H. K., Ayers, D. J., Walter, E. I., Getty, R. R., Groger, R. K., et al. (1988). Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3′ end sequence of decay-accelerating factor's mRNA. Proceedings of National Academy of Science United States of America, 85, 3555-3559.
22. Medof, M. E., Kinoshita, T., & Nussenzweig, V. (1984). Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. Journal of Experimental Medicine, 160, 1558-1578. (Pubitemid 15220783)
23. Zacharias, D. A., Violin, J. D., Newton, A. C., & Tsien, R. Y. (2002). Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science, 296, 913-916. (Pubitemid 34464897)
24. Steinrigl, A., Nosek, D., Ertl, R., Gunzburg, W. H., Salmons, B., & Klein, D. (2007). Mutations in the catalytic core or the C-terminus of murine leukemia virus (MLV) integrase disrupt virion infectivity and exert diverse effects on reverse transcription. Virology, 362, 50-59. (Pubitemid 46617690)
25. Ikeda, Y., Takeuchi, Y., Martin, F., Cosset, F. L., Mitrophanous, K., & Collins, M. (2003). Continuous high-titer HIV-1 vector production. Nature Biotechnology, 21, 569-572. (Pubitemid 36532025)
26. Lauc, G., & Heffer-Lauc, M. (2006). Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochimica et Biophysica Acta, 1760, 584-602.
27. Elortza, F., Mohammed, S., Bunkenborg, J., Foster, L. J., Nuhse, T. S., Brodbeck, U., et al. (2006). Modification-specific proteomics of plasma membrane proteins: Identification and characterization of glycosylphosphatidylinositol- anchored proteins released upon phospholipase D treatment. Journal of Proteome Research, 5, 935-943.
28. Miller, D. G., Edwards, R. H., & Miller, A. D. (1994). Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proceedings of National Academy of Science United States of America, 91, 78-82. (Pubitemid 24018646)
29. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., Desmyter, J., & De Clercq, E. (1988). Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proceedings of National Academy of Science United States of America, 85, 6132-6136.
30. Nakashima, H., Yoshida, O., Baba, M., De Clercq, E., & Yamamoto, N. (1989). Anti-HIV activity of dextran sulphate as determined under different experimental conditions. Antiviral Research, 11, 233-246. (Pubitemid 19182396)